Masimo Corp (MASI)
124.10
+3.49
(+2.89%)
USD |
NASDAQ |
May 17, 16:00
123.98
-0.12
(-0.10%)
After-Hours: 20:00
Masimo SG&A Expense (Annual): 664.00M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 664.00M |
| December 31, 2022 | 657.40M |
| December 31, 2021 | 395.40M |
| December 31, 2020 | 369.00M |
| December 31, 2019 | 314.66M |
| December 31, 2018 | 285.42M |
| December 31, 2017 | 273.01M |
| December 31, 2016 | 254.71M |
| December 31, 2015 | 252.72M |
| December 31, 2014 | 241.02M |
| December 31, 2013 | 215.47M |
| Date | Value |
|---|---|
| December 31, 2012 | 193.95M |
| December 31, 2011 | 169.20M |
| December 31, 2010 | 174.09M |
| December 31, 2009 | 134.88M |
| December 31, 2008 | 120.78M |
| December 31, 2007 | 91.23M |
| December 31, 2006 | 91.49M |
| December 31, 2005 | 43.08M |
| December 31, 2004 | |
| December 31, 2003 | 21.95M |
| December 31, 2002 | 14.64M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
314.66M
Minimum
2019
664.00M
Maximum
2023
480.09M
Average
395.40M
Median
2021
SG&A Expense (Annual) Benchmarks
| Boston Scientific Corp | 5.19B |
| Integer Holdings Corp | 175.62M |
| Stryker Corp | 7.129B |
| Insulet Corp | 734.90M |
| Shockwave Medical Inc | 330.10M |